{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:16:08Z","timestamp":1791306968583,"version":"4.3.1"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019305","name":"Manipal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019305","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119712","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:21:11Z","timestamp":1782246071000},"page":"119712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Bacoside-A from Bacopa monnieri (L.) Wettst. in Parkinson\u2019s disease: In Silico and preclinical insights into dopaminergic neuroprotection"],"prefix":"10.1016","volume":"201","author":[{"given":"Abhishek","family":"Dadhich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek Kumar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irra","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunidhi","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madan Mohan","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib1","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1186\/s12889-025-23492-8","article-title":"The global, regional, and National burden of parkinson\u2019s disease in 204 countries and territories, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"25","author":"Li","year":"2025","journal-title":"BMC Public. Health"},{"key":"10.1016\/j.biopha.2026.119712_bib2","first-page":"3","article-title":"Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis","author":"Kouli","year":"2018","journal-title":"Exon Publ."},{"issue":"11","key":"10.1016\/j.biopha.2026.119712_bib3","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nrd.2018.136","article-title":"Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs","volume":"17","author":"Charvin","year":"2018","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.biopha.2026.119712_bib4","doi-asserted-by":"crossref","unstructured":"M. A. Cenci, K. E. Ohlin, and P. Odin, \u201cCurrent Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson \u2019 s Disease,\u201d vol. 2, pp. 670\u2013684, 2011.","DOI":"10.2174\/187152711797247885"},{"key":"10.1016\/j.biopha.2026.119712_bib5","doi-asserted-by":"crossref","unstructured":"R. Kaitwad, A. Gulwe, C. Dipke, H. Suryawanshi, N. Murge, and D. Nalage, \u201cCurrent and emerging therapies for Parkinson \u2019 s disease: advances toward disease modification,\u201d vol. 8, no. 4, pp. 1\u201310, 2025, doi: 10.53388\/LR20250022.Peer.","DOI":"10.53388\/LR20250022"},{"issue":"11","key":"10.1016\/j.biopha.2026.119712_bib6","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/nm.2220","article-title":"Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the future","volume":"16","author":"Lang","year":"2010","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.biopha.2026.119712_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13031","article-title":"Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease","volume":"18","author":"Trist","year":"2019","journal-title":"Aging Cell."},{"issue":"7","key":"10.1016\/j.biopha.2026.119712_bib8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/17460441.2022.2072827","article-title":"What are the challenges with multi-targeted drug design for complex diseases?","volume":"17","author":"Zi\u0119ba","year":"2022","journal-title":"Expert. Opin. Drug. Discov."},{"issue":"7","key":"10.1016\/j.biopha.2026.119712_bib9","article-title":"Network Pharmacology: A Systems-Based Paradigm-DrivenMulti-Target Drug Discovery & Development","volume":"15","author":"Kumari","year":"2025","journal-title":"Eur. J. Cardiovasc. Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119712_bib10","article-title":"Co-assembly strategies of natural plant compounds for improving their bioavailability","volume":"2","author":"Miao","year":"2025","journal-title":"Food Med. Homol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1586\/ecp.12.74","article-title":"Polypharmacology: drug discovery for the future","volume":"6","author":"Reddy","year":"2013","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119712_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/nu17111939","article-title":"Bacopa monnieri: Preclinical and Clinical Evidence of Neuroactive Effects, Safety of Use and the Search for Improved Bioavailability","volume":"17","author":"Go\u015bciniak","year":"2025","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.biopha.2026.119712_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/rej.2013.1431","article-title":"Neuropharmacological Review of the Nootropic Herb Bacopa monnieri","volume":"16","author":"Aguiar","year":"2013","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.biopha.2026.119712_bib14","doi-asserted-by":"crossref","DOI":"10.2196\/82891","article-title":"Efficacy of Bacopa monnieri (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial","volume":"15","author":"Dwivedi","year":"2026","journal-title":"JMIR Res. Protoc."},{"key":"10.1016\/j.biopha.2026.119712_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jep.2016.07.073","article-title":"The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain","volume":"197","author":"Nemetchek","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2026.119712_bib16","first-page":"1","article-title":"Sodium chloride-induced metabolic shifts and morpho-physiological responses in Bacopa monnieri (L.) Wettst. for enhanced bacoside-A production","author":"Dadhich","year":"2024","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.biopha.2026.119712_bib17","series-title":"Bacosides and Neuroprotection BT - Natural Products: Phytochemistry, Botany, Metabolism of Alkaloids, Phenolics and Terpenes","first-page":"1","author":"Paul","year":"2025"},{"key":"10.1016\/j.biopha.2026.119712_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118466","article-title":"Bacoside-A from Bacopa monnieri (L.) Wettst.: Molecular targets, preclinical insights, and therapeutic potential in type 2 diabetes mellitus and neurodegeneration","volume":"191","author":"Dadhich","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.biopha.2026.119712_bib19","doi-asserted-by":"crossref","first-page":"10608","DOI":"10.3390\/ijms130810608","article-title":"Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson\u2019s disease","volume":"13","author":"Koppula","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119712_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.616413","article-title":"Neuroprotective and neurorescue mode of action of Bacopa monnieri (L.) Wettst in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson\u2019s disease: an in silico and in vivo study","volume":"12","author":"Singh","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s44371-025-00373-y","article-title":"Integrating phytochemicals and in silico methods for modern drug discovery: a comprehensive review","volume":"2","author":"Babalola","year":"2025","journal-title":"Discov. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2026.119712_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10863-019-09798-4","article-title":"Role of DJ-1 in the mechanism of pathogenesis of Parkinson\u2019s disease","volume":"51","author":"Dolgacheva","year":"2019","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.biopha.2026.119712_bib23","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fchem.2020.00726","article-title":"Computational Approaches in Preclinical Studies on Drug Discovery and Development","volume":"8","author":"Wu","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.biopha.2026.119712_bib24","doi-asserted-by":"crossref","unstructured":"M. Ferrucci et al., \u201cBacopa Protects against Neurotoxicity Induced by MPP+ and Methamphetamine,\u201d 2022. doi: 10.3390\/molecules27165204.","DOI":"10.3390\/molecules27165204"},{"issue":"7","key":"10.1016\/j.biopha.2026.119712_bib25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1517\/17460441.2015.1041495","article-title":"Rational drug discovery design approaches for treating Parkinson\u2019s disease","volume":"10","author":"Van der Schyf","year":"2015","journal-title":"Expert. Opin. Drug. Discov."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s43556-026-00445-0","article-title":"Parkinson\u2019s disease: pathogenesis and therapeutic strategies","volume":"7","author":"Zhang","year":"2026","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.biopha.2026.119712_bib27","first-page":"1107","article-title":"Hydrogen Sulfide: A Multitarget Therapeutic for Neuroinflammation in Neurodegenerative Diseases","volume":"9","author":"Zhang","year":"2026","journal-title":"Res. (Wash. D. C."},{"issue":"12","key":"10.1016\/j.biopha.2026.119712_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/0973-7847.99898","article-title":"Neuroprotective potential of phytochemicals","volume":"6","author":"Kumar","year":"2012","journal-title":"Pharmacogn. Rev."},{"issue":"9","key":"10.1016\/j.biopha.2026.119712_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094508","article-title":"Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson\u2019s Disease","volume":"23","author":"Guatteo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2026.119712_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70438","article-title":"When Pathways Converge: Iron, Lipid Peroxidation, and \u03b1-Synuclein in Ferroptosis-Driven Dopaminergic Neurodegeneration","volume":"170","author":"Sperlich","year":"2026","journal-title":"J. Neurochem."},{"issue":"18","key":"10.1016\/j.biopha.2026.119712_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26188907","article-title":"Neuroactive Phytochemicals as Multi-Target Modulators of Mental Health and Cognitive Function: An Integrative Review","volume":"26","author":"Tkaczenko","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"35","key":"10.1016\/j.biopha.2026.119712_bib32","doi-asserted-by":"crossref","first-page":"11011","DOI":"10.1523\/JNEUROSCI.2519-09.2009","article-title":"Robust pacemaking in substantia nigra dopaminergic neurons","volume":"29","author":"Guzman","year":"2009","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119712_bib33","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s42255-022-00594-w","article-title":"Mitochondrial heterogeneity and homeostasis through the lens of a neuron","volume":"4","author":"Pekkurnaz","year":"2022","journal-title":"Nat. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2026.119712_bib34","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson\u2019s disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"issue":"14","key":"10.1016\/j.biopha.2026.119712_bib35","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1038\/emboj.2012.170","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease: molecular mechanisms and pathophysiological consequences","volume":"31","author":"Exner","year":"2012","journal-title":"EMBO J."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2026.119712_bib36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0006-3207(96)00023-7","article-title":"Models of spatial spread: a synthesis","volume":"78","author":"Hastings","year":"1996","journal-title":"Biol. Conserv."},{"issue":"2","key":"10.1016\/j.biopha.2026.119712_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"24","key":"10.1016\/j.biopha.2026.119712_bib38","doi-asserted-by":"crossref","first-page":"9005","DOI":"10.1021\/es801777n","article-title":"Adsorption Mechanisms of Organic Chemicals on Carbon Nanotubes","volume":"42","author":"Pan","year":"2008","journal-title":"Environ. Sci. Technol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119712_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"\u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.biopha.2026.119712_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cells12071012","article-title":"Microglia Mediated Neuroinflammation in Parkinson\u2019s Disease","volume":"12","author":"Isik","year":"2023","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.biopha.2026.119712_bib41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119712_bib42","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib43","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","article-title":"Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances","volume":"10","author":"Xu","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2026.119712_bib44","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2174\/1570159X16666180419123022","article-title":"Insights Into the Molecular Aspects of Neuroprotective Bacoside A and Bacopaside I","volume":"17","author":"Sekhar","year":"2019","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010360","article-title":"Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson\u2019s Disease","volume":"25","author":"Saramowicz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119712_bib46","article-title":"Alpha-synuclein in Lewy bodies","author":"Spillantini","year":"1997","journal-title":"England"},{"issue":"5545","key":"10.1016\/j.biopha.2026.119712_bib47","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","article-title":"Kinetic stabilization of the \u03b1-synuclein protofibril by a dopamine-\u03b1-synuclein adduct","volume":"294","author":"Conway","year":"2001","journal-title":"Science (80-. )."},{"issue":"10","key":"10.1016\/j.biopha.2026.119712_bib48","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.biopha.2026.119712_bib49","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nri.2017.64","article-title":"The unique immunological and microbial aspects of pregnancy","volume":"17","author":"Mor","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"5688","key":"10.1016\/j.biopha.2026.119712_bib50","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired Degradation of Mutant \u03b1-Synuclein by Chaperone-Mediated Autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science (80-. )"},{"issue":"3","key":"10.1016\/j.biopha.2026.119712_bib51","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1175\/2009BAMS2865.1","article-title":"The Stratosphere\u2013Troposphere Analyses of Regional Transport 2008 Experiment","volume":"91","author":"Pan","year":"2010","journal-title":"Bull. Am. Meteorol. Soc."},{"issue":"7","key":"10.1016\/j.biopha.2026.119712_bib52","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2026.119712_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.736978","article-title":"Alpha-Synuclein Aggregation in Parkinson\u2019s Disease","volume":"8","author":"Srinivasan","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.biopha.2026.119712_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.852003","article-title":"Alpha-Synuclein Targeting Therapeutics for Parkinson\u2019s Disease and Related Synucleinopathies","volume":"13","author":"Menon","year":"2022","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119712_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27031324","article-title":"Interactions Between Nutraceuticals and \u03b1-Synuclein Conformational States: Molecular Mechanisms and Neuroprotective Implications in Parkinson\u2019s Disease","volume":"27","author":"Amenta","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119712_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126565","article-title":"Silico and In Vitro Analysis of Bacoside A Aglycones and Its Derivatives as the Constituents Responsible for the Cognitive Effects of Bacopa monnieri","volume":"10","author":"Ramasamy","year":"2015","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1021\/acschemneuro.5c00323","article-title":"Synuclein and Mitochondrial Dysfunction: Regulating the Protein Import Complex toward PD Treatment?","volume":"17","author":"Dash","year":"2026","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119712_bib58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","article-title":"Mitochondrial Dysfunction in Parkinson\u2019s Disease","volume":"24","author":"Moon","year":"2015","journal-title":"Exp. Neurobiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib59","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/toxsci\/kfl133","article-title":"Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"95","author":"Richardson","year":"2007","journal-title":"Toxicol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119712_bib60","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11306-024-02181-4","article-title":"Dopaminergic neuron metabolism: relevance for understanding Parkinson\u2019s disease","volume":"20","author":"Flores-Ponce","year":"2024","journal-title":"Metabolomics"},{"key":"10.1016\/j.biopha.2026.119712_bib61","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neuroscience.2011.08.045","article-title":"The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson\u2019s disease","volume":"198","author":"Surmeier","year":"2011","journal-title":"Neuroscience"},{"issue":"24","key":"10.1016\/j.biopha.2026.119712_bib62","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1016\/j.febslet.2015.10.021","article-title":"Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson\u2019s disease","volume":"589","author":"Haddad","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2026.119712_bib63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1326-4-24","article-title":"Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson\u2019s disease: how neurons are lost in the Bermuda triangle","volume":"4","author":"Malkus","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.biopha.2026.119712_bib64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease","volume":"106\u2013107","author":"Subramaniam","year":"2013","journal-title":"Prog. Neurobiol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119712_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/biom11050718","article-title":"Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson\u2019s Disease: The Emerging Role of VDAC","volume":"11","author":"Risiglione","year":"2021","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.biopha.2026.119712_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.71023","article-title":"Aggregation and Propagation of \u03b1-Synuclein in Parkinson\u2019s Disease: A Bibliometric Perspective","volume":"15","author":"Zhang","year":"2025","journal-title":"Brain Behav."},{"issue":"2","key":"10.1016\/j.biopha.2026.119712_bib67","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.biopha.2026.119712_bib68","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12035-010-8150-4","article-title":"Mitochondrial quality control and Parkinson\u2019s disease: a pathway unfolds","volume":"43","author":"de Castro","year":"2011","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib69","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","article-title":"Mitochondrial dysfunction: mechanisms and advances in therapy","volume":"9","author":"Zong","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2026.119712_bib70","first-page":"643","article-title":"Decoding natural products for neuroprotection: Pathway networks and structural insights for drug development","volume":"17","author":"Ghosh","year":"2025","journal-title":"Chin. Herb. Med."},{"issue":"Pt 8","key":"10.1016\/j.biopha.2026.119712_bib71","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/brain\/awm318","article-title":"The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson\u2019s disease","volume":"131","author":"Pan","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2026.119712_bib72","article-title":"\u03b1-Synuclein ubiquitination \u2013 functions in proteostasis and development of Lewy bodies","volume":"17-2024","author":"Ho","year":"2024","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib73","article-title":"The role of autophagy in synucleinopathy: clearance versus spread of \u03b1-synuclein","volume":"4","author":"Birnbaum","year":"2025","journal-title":"Autophagy Rep."},{"issue":"24","key":"10.1016\/j.biopha.2026.119712_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/cells14241976","article-title":"Maintenance and Decline of Neuronal Lysosomal Function in Aging","volume":"14","author":"Zhong","year":"2025","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.biopha.2026.119712_bib75","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s43587-021-00098-4","article-title":"Autophagy in healthy aging and disease","volume":"1","author":"Aman","year":"2021","journal-title":"Nat. Aging"},{"issue":"5","key":"10.1016\/j.biopha.2026.119712_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/nu18050863","article-title":"Mechanistic Modulation of Autophagy by Bioactive Natural Products: Implications for Human Aging and Longevity","volume":"18","author":"Jalouli","year":"2026","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.biopha.2026.119712_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson\u2019s Disease: Mechanisms and Therapeutic Implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119712_bib78","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-2-14","article-title":"Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition","volume":"2","author":"Croisier","year":"2005","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib79","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib80","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00018-025-05985-2","article-title":"Revisiting the alpha-synuclein paradox in melanoma-Parkinson\u2019s disease connection: more than a tale of two cell fates","volume":"83","author":"Aiello","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"issue":"23","key":"10.1016\/j.biopha.2026.119712_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13237243","article-title":"Alpha-Synuclein and Microglia in Parkinson\u2019s Disease: From Pathogenesis to Therapeutic Prospects","volume":"13","author":"Eo","year":"2024","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.biopha.2026.119712_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065914","article-title":"Alpha Synuclein: Neurodegeneration and Inflammation","volume":"24","author":"Forloni","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119712_bib83","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70268","article-title":"Oxidative Stress: Signaling Pathways, Biological Functions, and Disease","volume":"6","author":"Liu","year":"2025","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib84","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40035-026-00540-w","article-title":"Mitochondrial DNA: a molecular switch driving sterile neuroinflammation","volume":"15","author":"Jauhari","year":"2026","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines14010058","article-title":"Glial Activation, Neuroinflammation, and Loss of Neuroprotection in Chronic Pain: Cellular Mechanisms and Emerging Therapeutic Strategies","volume":"14","author":"McKenzie","year":"2025","journal-title":"Biomedicines"},{"issue":"Pt A","key":"10.1016\/j.biopha.2026.119712_bib86","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuropharm.2014.10.028","article-title":"Microglial priming and enhanced reactivity to secondary insult in aging, and traumatic CNS injury, and neurodegenerative disease","volume":"96","author":"Norden","year":"2015","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.biopha.2026.119712_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70299","article-title":"Astrocyte in Neurological Disease: Pathogenesis and Therapy","volume":"6","author":"Huang","year":"2025","journal-title":"MedComm"},{"issue":"3","key":"10.1016\/j.biopha.2026.119712_bib88","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/neurolint16030037","article-title":"Oxidative Stress and Neurodegeneration: Insights and Therapeutic Strategies for Parkinson\u2019s Disease","volume":"16","author":"Bej","year":"2024","journal-title":"Neurol. Int."},{"issue":"16","key":"10.1016\/j.biopha.2026.119712_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26164886","article-title":"Overview of the Antioxidant and Anti-Inflammatory Activities of Selected Plant Compounds and Their Metal Ions Complexes","volume":"26","author":"Mucha","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119712_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.580634","article-title":"The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson\u2019s Disease","volume":"8","author":"Minakaki","year":"2020","journal-title":"Front. Cell. Dev. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119712_bib91","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/s43587-026-01067-5","article-title":"Aging clocks delineate neuron types vulnerable or resilient to neurodegeneration and identify neuroprotective interventions","volume":"6","author":"Gallrein","year":"2026","journal-title":"Nat. Aging"},{"key":"10.1016\/j.biopha.2026.119712_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.plana.2024.100133","article-title":"Bacopa monnieri (L.) Wettst. plant extract mediated synthesis of metallic nanoparticles and regulation of bacoside-A- memory enhancer compound and their application: A comprehensive review","volume":"11","author":"Dadhich","year":"2025","journal-title":"Plant. Nano Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib93","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13024-024-00756-2","article-title":"\u03b1-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson\u2019s disease","volume":"19","author":"Geibl","year":"2024","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib94","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-022-00524-0","article-title":"Solving neurodegeneration: common mechanisms and strategies for new treatments","volume":"17","author":"Wareham","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.biopha.2026.119712_bib95","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.4103\/NRR.NRR-D-24-01507","article-title":"Inherent potential of mitochondria-targeted interventions for chronic neurodegenerative diseases","volume":"21","author":"Zhou","year":"2026","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2026.119712_bib96","doi-asserted-by":"crossref","DOI":"10.1177\/1177392819866412","article-title":"Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Properties, Mechanisms of Action, and Preclinical and Clinical Studies","volume":"13","author":"Abdul Manap","year":"2019","journal-title":"Drug. Target. Insights"},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib97","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41531-025-00998-x","article-title":"Chronic stress induces depression-like behaviors and Parkinsonism via upregulating \u03b1-synuclein","volume":"11","author":"Xia","year":"2025","journal-title":"NPJ Park. Dis."},{"issue":"11","key":"10.1016\/j.biopha.2026.119712_bib98","article-title":"Oxidative Stress, Mitochondrial Function and Adaptation to Exercise: New Perspectives in Nutrition","volume":"11","author":"Vargas-Mendoza","year":"2021","journal-title":"Life (Basel Switz. )"},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib99","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/toxsci\/kfr255","article-title":"Standardized extracts of Bacopa monniera protect against MPP+- and paraquat-induced toxicity by modulating mitochondrial activities, proteasomal functions, and redox pathways","volume":"125","author":"Singh","year":"2012","journal-title":"Toxicol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2026.119712_bib100","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1089\/ars.2011.4123","article-title":"Redox regulation of mitochondrial function","volume":"16","author":"Handy","year":"2012","journal-title":"Antioxid. Redox Signal."},{"issue":"Pt B","key":"10.1016\/j.biopha.2026.119712_bib101","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.expneurol.2017.10.003","article-title":"Therapeutic approaches to target alpha-synuclein pathology","volume":"298","author":"Brundin","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2026.119712_bib102","doi-asserted-by":"crossref","unstructured":"C.D. Toderescu, I. Cresneac, A. Oancea, S. Trifunschi, M.F. Munteanu, and C. Boru, \u201cPlant-Derived Nanomaterials and Protein Misfolding Disorders: Green Production Approaches, Biological Interactions, and Research Trends (2015\u20132025),\u201d 2026. doi: 10.3390\/app16052620.","DOI":"10.3390\/app16052620"},{"key":"10.1016\/j.biopha.2026.119712_bib103","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.phymed.2003.12.008","article-title":"Bacopa Monniera, A reputed nootropic plant: An overview","volume":"12","author":"Russo","year":"2005","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib104","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jep.2013.11.008","article-title":"Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract","volume":"151","author":"Kongkeaw","year":"2014","journal-title":"J. Ethnopharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119712_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072517","article-title":"Evaluation of Memory Enhancing Clinically Available Standardized Extract of Bacopa monniera on P-Glycoprotein and Cytochrome P450 3A in Sprague-Dawley Rats","volume":"8","author":"Singh","year":"2013","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib106","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11064-010-0253-9","article-title":"Behavioral Deficit and Decreased GABA Receptor Functional Regulation in the Hippocampus of Epileptic Rats: Effect of Bacopa monnieri","volume":"36","author":"Mathew","year":"2011","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.biopha.2026.119712_bib107","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s11307-023-01814-9","article-title":"Identification of a Putative \u03b1-synuclein Radioligand Using an in silico Similarity Search","volume":"25","author":"Janssen","year":"2023","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.biopha.2026.119712_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.117899","article-title":"Assessment of the mechanistic role of an Indian traditionally used ayurvedic herb Bacopa monnieri (L.)Wettst. In ameliorating oxidative stress in neuronal cells","volume":"328","author":"Ghosh","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib109","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41531-025-01167-w","article-title":"\u03b1-synuclein in Parkinson\u2019s disease: a central point of convergence with depression","volume":"11","author":"Yusuf","year":"2025","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.biopha.2026.119712_bib110","doi-asserted-by":"crossref","unstructured":"M.N. Park, M. Choi, R.A. Syahputra, D.V. Delfino, S.-G. Ko, and B. Kim, \u201cRedox Homeostasis as a Therapeutic Target in Chronic Oxidative Diseases: Implications for Cancer Treatment,\u201d 2026. doi: 10.3390\/antiox15020203.","DOI":"10.3390\/antiox15020203"},{"issue":"3","key":"10.1016\/j.biopha.2026.119712_bib111","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/(SICI)1099-1573(200005)14:3<174::AID-PTR624>3.0.CO;2-O","article-title":"Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus","volume":"14","author":"Bhattacharya","year":"2000","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib112","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11064-012-0902-2","article-title":"Bacopa monnieri and L-deprenyl differentially enhance the activities of antioxidant enzymes and the expression of tyrosine hydroxylase and nerve growth factor via ERK 1\/2 and NF-\u03baB pathways in the spleen of female wistar rats","volume":"38","author":"Priyanka","year":"2013","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.biopha.2026.119712_bib113","first-page":"312","article-title":"Gutteridge, \u201cfree radical: free radical is any stable chemical specimen that contains at least","volume":"141","author":"Halliwell","year":"2006","journal-title":"Life"},{"issue":"3","key":"10.1016\/j.biopha.2026.119712_bib114","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11011-019-00526-w","article-title":"Neuroprotective effects of Bacopa monnieri in Parkinson\u2019s disease model","volume":"35","author":"Singh","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.biopha.2026.119712_bib115","article-title":"Oxidative Stress: A New Pathophysiological Pathway in Parkinson\u2019s Disease and a Potential Target of the Brain-Sport Crosstalk","volume":"2025","author":"Caproni","year":"2025","journal-title":"Park. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib116","first-page":"S287","article-title":"Monoamine oxidase: isoforms and inhibitors in Parkinson\u2019s disease and depressive illness","volume":"147","author":"Youdim","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119712_bib117","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/17425255.2017.1273901","article-title":"Use of monoamine oxidase inhibitors in chronic neurodegeneration","volume":"13","author":"Riederer","year":"2017","journal-title":"Expert. Opin. Drug. Metab. Toxicol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119712_bib118","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2174\/1389450123666220316091734","article-title":"A Comprehensive Review on Preclinical Evidence-based Neuroprotective Potential of Bacopa monnieri against Parkinson\u2019s Disease","volume":"23","author":"Goyal","year":"2022","journal-title":"Curr. Drug. Targets"},{"key":"10.1016\/j.biopha.2026.119712_bib119","doi-asserted-by":"crossref","unstructured":"L.V. Ribeiro, L.E. Massuda, V.S. Gontijo, and C. Viegas, \u201cMonoamine Oxidase Inhibitors in Drug Discovery Against Parkinson\u2019s Disease: An Update,\u201d 2025. doi: 10.3390\/ph18101526.","DOI":"10.20944\/preprints202508.1652.v1"},{"key":"10.1016\/j.biopha.2026.119712_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.972379","article-title":"Pharmacological attributes of Bacopa monnieri extract: Current updates and clinical manifestation","volume":"9","author":"Fatima","year":"2022","journal-title":"Front. Nutr."},{"issue":"12","key":"10.1016\/j.biopha.2026.119712_bib121","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.tins.2010.09.004","article-title":"\u03b1-Synuclein and dopamine at the crossroads of Parkinson\u2019s disease","volume":"33","author":"Venda","year":"2010","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119712_bib122","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0022-2836(65)80068-7","article-title":"Electron microscopic studies on the serum albumin molecules","volume":"11","author":"Chatterjee","year":"1965","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119712_bib123","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jcsm.12654","article-title":"Effects of statins on mitochondrial pathways","volume":"12","author":"Mollazadeh","year":"2021","journal-title":"J. Cachex-.-. Sarcopenia Muscle"},{"key":"10.1016\/j.biopha.2026.119712_bib124","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.colsurfb.2016.02.003","article-title":"Role of amphipathicity and hydrophobicity in the balance between hemolysis and peptide-membrane interactions of three related antimicrobial peptides","volume":"141","author":"Hollmann","year":"2016","journal-title":"Colloids Surf. B. Biointerfaces"},{"issue":"4","key":"10.1016\/j.biopha.2026.119712_bib125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s13659-014-0031-5","article-title":"Molecular docking of bacosides with tryptophan hydroxylase: a model to understand the bacosides mechanism","volume":"4","author":"Rajathei","year":"2014","journal-title":"Nat. Prod. Bioprospect"},{"issue":"2\u20133","key":"10.1016\/j.biopha.2026.119712_bib126","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1078\/0944-7113-00351","article-title":"The need for establishing identities of \u2018bacoside A and B\u2019, the putative major bioactive saponins of Indian medicinal plant Bacopa monnieri","volume":"11","author":"Deepak","year":"2004","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2026.119712_bib127","doi-asserted-by":"crossref","unstructured":"R. Vaja and M. Rana, \u201cDrugs and the liver.,\u201d Oct. 2020. doi: 10.1016\/j.mpaic.2020.07.001.","DOI":"10.1016\/j.mpaic.2020.07.001"},{"key":"10.1016\/j.biopha.2026.119712_bib128","article-title":"The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates","volume":"12-2021","author":"J\u00e4rvinen","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119712_bib129","article-title":"Role of Oxidative Stress in Blood-Brain Barrier Disruption and Neurodegenerative Diseases","volume":"13","author":"Kim","year":"2024","journal-title":"Antioxid. (Basel Switz. )"},{"issue":"4","key":"10.1016\/j.biopha.2026.119712_bib130","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/acschemneuro.6b00438","article-title":"Bacoside-A, an Indian traditional-medicine substance, inhibits \u03b2-amyloid cytotoxicity, fibrillation, and membrane interactions","volume":"8","author":"Malishev","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"23","key":"10.1016\/j.biopha.2026.119712_bib131","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.phytochem.2005.09.016","article-title":"Triterpenoid glycosides from Bacopa monnieri","volume":"66","author":"Sivaramakrishna","year":"2005","journal-title":"Phytochemistry"},{"key":"10.1016\/j.biopha.2026.119712_bib132","article-title":"Molecular docking studies of bacoside from Bacopa monnieri with LRRK2 receptor","volume":"68","author":"Jain","year":"2013","journal-title":"Biol. (Bratisl. )"},{"issue":"3","key":"10.1016\/j.biopha.2026.119712_bib133","doi-asserted-by":"crossref","first-page":"217","DOI":"10.6026\/973206300200217","article-title":"Molecular docking analysis of \u03b1-Synuclein aggregation with Anle138b","volume":"20","author":"Grewal","year":"2024","journal-title":"Bioinformation"},{"issue":"23","key":"10.1016\/j.biopha.2026.119712_bib134","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1007\/s00018-019-03203-4","article-title":"Mechanisms of PINK1, ubiquitin and Parkin interactions in mitochondrial quality control and beyond","volume":"76","author":"Bayne","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2026.119712_bib135","first-page":"1","article-title":"Molecular docking studies of Bacoside-A, an active component of Bacopa monniera with DJ1 for Anti-Parkinson\u2019s drug design","volume":"4","author":"Chandrasekar","year":"2013","journal-title":"Biomirror"},{"issue":"5","key":"10.1016\/j.biopha.2026.119712_bib136","doi-asserted-by":"crossref","DOI":"10.3390\/molecules31050848","article-title":"Computational and Molecular Dynamics Insights into the Antithrombotic Mechanism of Triterpenes Derived from Melaleuca bracteata var. Revolution Gold (Myrtaceae)","volume":"31","author":"Appiah-Kubi","year":"2026","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib137","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-026-05792-1","article-title":"Identification and Experimental Validation of Biomarkers Associated with PI3K\/AKT Signaling Pathway in Spinal Cord Injury","volume":"63","author":"Chen","year":"2026","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib138","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: Structure, regulation and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib139","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/febs.70222","article-title":"Hydrophobic residues in the \u03b1-synuclein NAC domain drive seed-competent fibril formation and are targeted by peptide inhibitors","volume":"293","author":"Das","year":"2026","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.biopha.2026.119712_bib140","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11064-025-04520-w","article-title":"Comparative Molecular Dynamics Reveals How LRRK2 Inhibitors Distinguish G2019S from Wild-Type","volume":"50","author":"Wei","year":"2025","journal-title":"Neurochem. Res."},{"issue":"25","key":"10.1016\/j.biopha.2026.119712_bib141","doi-asserted-by":"crossref","first-page":"26208","DOI":"10.1021\/acsomega.5c00134","article-title":"New Prospects in the Inhibition of Monoamine Oxidase\u2011B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer\u2019s Disease: A Review","volume":"10","author":"Chatzipieris","year":"2025","journal-title":"ACS Omega"},{"issue":"12","key":"10.1016\/j.biopha.2026.119712_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102704","article-title":"The interaction between E3 ubiquitin ligase Parkin and mitophagy receptor PHB2 links inner mitochondrial membrane ubiquitination to efficient mitophagy","volume":"298","author":"Sun","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119712_bib143","article-title":"PINK1 deficiency enhances autophagy and mitophagy induction","volume":"3","author":"G\u00f3mez-S\u00e1nchez","year":"2016","journal-title":"Mol. Cell. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119712_bib144","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neures.2010.04.002","article-title":"DJ-1 protects against oxidative damage by regulating the thioredoxin\/ASK1 complex","volume":"67","author":"Im","year":"2010","journal-title":"Neurosci. Res."},{"issue":"33","key":"10.1016\/j.biopha.2026.119712_bib145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/0973-1296.108140","article-title":"Dietary phytochemicals as potent chemotherapeutic agents against breast cancer: Inhibition of NF-\u03baB pathway via molecular interactions in rel homology domain of its precursor protein p105","volume":"9","author":"Khan","year":"2013","journal-title":"Pharmacogn. Mag."},{"key":"10.1016\/j.biopha.2026.119712_bib146","article-title":"Bacopa monnieri as an antioxidant therapy to reduce oxidative stress in the aging brain","volume":"2015","author":"Simpson","year":"2015","journal-title":"Evid. Based Complement. Altern. Med. Vol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119712_bib147","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.taap.2011.07.021","article-title":"Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKC\u03b4 in cell culture and animal models of Parkinson\u2019s disease","volume":"256","author":"Latchoumycandane","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119712_bib148","doi-asserted-by":"crossref","first-page":"923","DOI":"10.17305\/bb.2024.10181","article-title":"Comprehensive in vitro and in ovo assessment of cytotoxicity: unraveling the impact of sodium fluoride, xylitol, and their synergistic associations in dental products","volume":"24","author":"Breban-Schwarzkopf","year":"2024","journal-title":"Biomol. Biomed."},{"key":"10.1016\/j.biopha.2026.119712_bib149","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s11064-012-0717-1","article-title":"Bacopa monniera (L.) Wettst ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats","volume":"37","author":"Sandhya","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2026.119712_bib150","doi-asserted-by":"crossref","first-page":"15017","DOI":"10.2147\/IJN.S564106","article-title":"Nasal delivery of phytochemicals using nanocarriers: therapeutic opportunities and translational challenges","volume":"20","author":"Egba","year":"2025","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.biopha.2026.119712_bib151","doi-asserted-by":"crossref","first-page":"41","DOI":"10.18053\/jctres.09.202301.007","article-title":"Bacopa monnieri supplementation has no effect on serum brain-derived neurotrophic factor levels but beneficially modulates nuclear factor kappa B and cyclic AMP response element-binding protein levels in healthy elderly subjects","volume":"9","author":"Keegan","year":"2023","journal-title":"J. Clin. Transl. Res."},{"issue":"12","key":"10.1016\/j.biopha.2026.119712_bib152","article-title":"Transcriptome-wide miRNA identification of Bacopa monnieri: a cross-kingdom approach","volume":"14","author":"Gadhavi","year":"2019","journal-title":"Plant. Signal. & Behav."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:43:05Z","timestamp":1784529785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226007481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":152,"alternative-id":["S0753332226007481"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119712","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacoside-A from Bacopa monnieri (L.) Wettst. in Parkinson\u2019s disease: In Silico and preclinical insights into dopaminergic neuroprotection","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119712","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119712"}}